secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rein Therapeutics, Inc. (RNTX)
CIK:        0001420565
Form:       8-K
Filed at:   2024-08-21T23:59:59+00:00
Accession:  0001193125-24-204425
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aileron Therapeutics 2024 annual meeting: re-elects directors, ratifies auditor
-------------------------------------------------------------------------------

- Re-elected Brian Windsor, Ph.D. and Alan A. Musso as Class I directors (7.8M for, ~24k withheld each, 3.4M broker non-votes).
- Advisory vote on named executive officer compensation passed: 7.3M for, 109k against, 416k abstain.
- Ratified Marcum LLP as independent auditor for FY 2024: 10.8M for, 61k against, 416k abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420565/000119312524204425/0001193125-24-204425-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420565/000119312524204425/d862681d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-204425

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer